<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02080741</url>
  </required_header>
  <id_info>
    <org_study_id>CHAUVET-GELINIER APJ 2013</org_study_id>
    <nct_id>NCT02080741</nct_id>
  </id_info>
  <brief_title>Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile</brief_title>
  <acronym>Diatolepsy</acronym>
  <official_title>Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      This study will include 100 patients with Type 1 and Type 2 diabetes, split into 2 groups of
      50 patients according to their behaviour type, and their adaptation to different factors of
      stress encountered in their lives:

        -  the first group will consist of patients with a characteristic Type A behaviour profile,
           that is to say patients with a &quot;proactive, impatient&quot; behaviour pattern

        -  the second group will consist of patients with a characteristic Type B behaviour profile
           that is to say patients with a &quot;calm, slow&quot; behaviour pattern The objective is to know
           if the different behaviour patterns are associated with distinct biological markers
           likely to influence the evolution of the diabetes.

      Participation in this study will be approximately 1h30, patients will participate ONCE ONLY:

        1. they will answer simple questions about their disease and then complete 3 questionnaires
           each with 14 items.

        2. they will meet a clinical psychologist for an interview lasting approximately 45 minutes
           recorded on an audio recorder. The consultation will be used to seek links between the
           psyche and the disease.

        3. they will provide one blood sample of 12 ml (equivalent to a soup spoon) drawn in the
           morning.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2014</start_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Telomere length</measure>
    <time_frame>Baselines</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of expression of candidate genes</measure>
    <time_frame>Baselines</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Complications of diabetes (Nephropathy, Retinopathy, Neuropathy, Coronaropathy)</measure>
    <time_frame>Baselines</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Scores on psychiatric/psychological scales</measure>
    <time_frame>Baselines</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Analysis of the specific psychological interview EMIC</measure>
    <time_frame>Baselines</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Patients With Type 1 or Type 2 Diabetes</condition>
  <condition>Patients With a Type A or B Behaviour Profile</condition>
  <arm_group>
    <arm_group_label>Type A behaviour profile</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Type B behaviour profile</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sample of 12 ml</intervention_name>
    <arm_group_label>Type A behaviour profile</arm_group_label>
    <arm_group_label>Type B behaviour profile</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have provided written informed consent

          -  Patients with type 1 or type 2 diabetes

          -  Patient admitted for a consultation, as out or in-patients to the
             Endocrinology-Diabetology-Metabolic diseases department of Dijon CHU

          -  Patient &gt; 18 years

          -  Patient with either a characteristic Type A behaviour profile (Bortner &gt; 210), or a
             characteristic Type B behaviour profile (Bortner&lt;154)

        Exclusion Criteria:

          -  Persons not covered by national health insurance

          -  Adults under guardianship or wards of court or not intellectually independent

          -  Patients without diabetes

          -  Patients with a mixed A/B behaviour profile (154&lt; Bortner score &lt;210)

          -  Pregnant or breast-feeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-Christophe CHAUVET-GELINIER</last_name>
    <phone>3.80.29.37.69</phone>
    <phone_ext>+33</phone_ext>
    <email>jean-christophe.chauvet-gelinier@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de DIJON</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Christophe CHAUVET-GELINIER</last_name>
      <phone>3.80.29.37.69</phone>
      <phone_ext>+33</phone_ext>
      <email>jean-christophe.chauvet-gelinier@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2014</study_first_submitted>
  <study_first_submitted_qc>March 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2014</study_first_posted>
  <last_update_submitted>December 3, 2014</last_update_submitted>
  <last_update_submitted_qc>December 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

